Follow
Davoud Ahmadvand
Davoud Ahmadvand
Verified email at iums.ac.ir
Title
Cited by
Cited by
Year
Material properties in complement activation
SM Moghimi, AJ Andersen, D Ahmadvand, PP Wibroe, TL Andresen, ...
Advanced drug delivery reviews 63 (12), 1000-1007, 2011
2772011
An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
PP Wibroe, D Ahmadvand, MA Oghabian, A Yaghmur, SM Moghimi
Journal of Controlled Release 221, 1-8, 2016
1912016
Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: The challenges ahead
SM Moghimi, AJ Andersen, SH Hashemi, B Lettiero, D Ahmadvand, ...
Journal of controlled release 146 (2), 175-181, 2010
1892010
Nanobody; an old concept and new vehicle for immunotargeting
F Rahbarizadeh, D Ahmadvand, Z Sharifzadeh
Immunological investigations 40 (3), 299-338, 2011
1242011
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide
LP Wu, D Ahmadvand, J Su, A Hall, X Tan, ZS Farhangrazi, SM Moghimi
Nature communications 10 (1), 4635, 2019
1112019
T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy
FR Jamnani, F Rahbarizadeh, MA Shokrgozar, F Mahboudi, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (1), 378-386, 2014
972014
Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents
Z Sharifzadeh, F Rahbarizadeh, MA Shokrgozar, D Ahmadvand, ...
Cancer letters 334 (2), 237-244, 2013
822013
Particulate systems for targeting of macrophages: basic and therapeutic concepts
SM Moghimi, L Parhamifar, D Ahmadvand, PP Wibroe, TL Andresen, ...
Journal of innate immunity 4 (5-6), 509-528, 2012
812012
Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing …
E Sadeqzadeh, F Rahbarizadeh, D Ahmadvand, MJ Rasaee, ...
Journal of controlled release 156 (1), 85-91, 2011
762011
Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells
FR Jamnani, F Rahbarizadeh, MA Shokrgozar, D Ahmadvand, ...
Experimental cell research 318 (10), 1112-1124, 2012
652012
Anti-MUC1 nanobody can redirect T-body cytotoxic effector function
SHA Bakhtiari, F Rahbarizadeh, S Hasannia, D Ahmadvand, FJ Iri-Sofla, ...
Hybridoma 28 (2), 85-92, 2009
562009
Cell selection and characterization of a novel human endothelial cell specific nanobody
D Ahmadvand, MJ Rasaee, F Rahbarizadeh, RE Kontermann, ...
Molecular immunology 46 (8-9), 1814-1823, 2009
532009
Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by PhiC31 integrase
FJ Iri-Sofla, F Rahbarizadeh, D Ahmadvand, MJ Rasaee
Experimental cell research 317 (18), 2630-2641, 2011
492011
A caspase 8-based suicide switch induces apoptosis in nanobody-directed chimeric receptor expressing T cells
S Khaleghi, F Rahbarizadeh, D Ahmadvand, MJ Rasaee, P Pognonec
International journal of hematology 95, 434-444, 2012
472012
A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment
Z Farajpour, F Rahbarizadeh, B Kazemi, D Ahmadvand
Biochemical and biophysical research communications 446 (1), 132-136, 2014
462014
Microfluidic platform for the continuous production and characterization of multilamellar vesicles: A synchrotron small-angle X-ray scattering (SAXS) study
A Ghazal, M Gontsarik, JP Kutter, JP Lafleur, D Ahmadvand, A Labrador, ...
The journal of physical chemistry letters 8 (1), 73-79, 2017
442017
The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected …
F Hajiahmadi, MY Alikhani, H Shariatifar, MR Arabestani, D Ahmadvand
International journal of nanomedicine, 5943-5955, 2019
412019
Development of gold-coated magnetic nanoparticles as a potential MRI contrast agent
AR Montazerabadi, MA Oghabian, R Irajirad, S Muhammadnejad, ...
Nano 10 (04), 1550048, 2015
392015
CAR T-cell bioengineering: single variable domain of heavy chain antibody targeted CARs
F Rahbarizadeh, D Ahmadvand, SM Moghimi
Advanced Drug Delivery Reviews 141, 41-46, 2019
362019
ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals
L Ordóñez-Gutiérrez, A Posado-Fernández, D Ahmadvand, B Lettiero, ...
Biomaterials 112, 141-152, 2017
362017
The system can't perform the operation now. Try again later.
Articles 1–20